About Rodney
Rodney has helped develop strategies for clients responding to major market disruptions, such as US healthcare reform, and Research and Development productivity challenges. He has worked extensively on mergers and acquisitions, partnerships, reorganizations, and post-merger integrations. He has also supported launch and growth strategies for a number of leading products in the US, Europe, and Japan, helping deliver important benefits to patients and improved business results for clients. He has led McKinsey’s support for a number of private equity clients investing in healthcare.
Rodney has authored articles in leading healthcare business publications such as Nature Drug Discovery and In Vivo on the topics of Research and Development and innovation. He contributes to research efforts by the McKinsey Global Institute and is also a frequent speaker at industry conferences.
He received a PhD in molecular biology, along with a first-class BA/MA degree in natural sciences, all from Trinity College, Cambridge, UK. Rodney has served on the board of directors of the Juvenile Diabetes Research Foundation.
Published work
“Accounting for the cost of U.S. health care: Pre-reform trends and the impact of the recession,” McKinsey Center for US Health System Reform, December 2011
“Invention reinvented,” McKinsey perspectives on pharmaceutical R&D, 2010
Education
| Trinity College, Cambridge University |
Molecular Biology |
PhD |
| Trinity College, Cambridge University |
Natural Sciences |
MA |
| Trinity College, Cambridge University |
Natural Sciences |
BA |